IPO Initial Public Offerings Market : Bullish and Bearish Analyst Opinions

IPO and M&A pipeline remains strong.

"The IPO pipeline looks healthy across the board... The US will probably see a lot of blockbuster IPOs for some of these companies, once in a generational companies like SpaceX and Anthropics." The entry of high-profile, generational companies into the public markets will absorb significant institutional liquidity and revitalize interest in new issues, raising the quality bar for the broader IPO market. WATCH the IPO ETF and new public listings as blockbuster names come to market and shift liquidity dynamics. Market volatility or a higher-for-longer interest rate environment could delay these highly anticipated listings.

"Does it create a vacuum? Is anyone else going to try to go public in June if Elon Musk is out there marketing this deal?" Capital is finite in the short term. A $1.75T asset listing sucks all the oxygen (capital and attention) out of the room. Any other company attempting to IPO in the June window will likely face a "capital strike" or be forced to price at a steep discount because bankers are focused entirely on SpaceX. AVOID non-SpaceX IPOs targeting a June listing. The market liquidity is deeper than expected and can absorb multiple deals.

"So many announced private companies, including... space exploration companies and Frontier AI labs that are expected to be entering the public markets." Tenev is signaling a robust IPO pipeline. When high-profile "story stocks" (like SpaceX or major AI labs) go public, retail participation spikes. This creates a flywheel effect: high-hype IPOs draw users to brokerages, increasing volume and margin balances. LONG. Position for a resurgence in the IPO market and the specific sectors (Space/AI) leading it. Macroeconomic tightening could freeze the IPO window; valuation concerns for new listings.

Databricks is delaying its IPO despite being free cash flow positive. The company prefers private capitalization to weather potential public market volatility (fearing a repeat of 2022). They want to invest in long-term R&D (5-10 years) without the quarterly pressure to cut costs or layoff staff if the stock drops. Raised Series L funding specifically to stay private longer. Prolonged delay could fatigue early employees or investors seeking liquidity.